Besides improving NO-availability, ivabradine was shown to reduce serum angiotensin II in both post-MI rats (25) and hypercholesterolemic rabbits (26), and to decrease serum aldosterone in L-NAME-induced hypertension (7). Here, AGT is linked to Hypertension.